Search results
Results from the WOW.Com Content Network
Discover Oncology, formerly Hormones and Cancer, is a bimonthly peer-reviewed medical journal covering research on all aspects of hormone action on cancer. It was established in 2010 and is published by Springer Science + Business Media on behalf of The Endocrine Society. The editor-in-chief is Carol A. Lange (University of Minnesota).
JCO Global Oncology is a peer-reviewed open-access medical journal covering cancer care, research, and care delivery issues unique to countries and settings with limited healthcare resources. It was established in 2015 as the Journal of Global Oncology , obtaining its current name in 2020.
Download as PDF; Printable version; ... ISO 4: Cancer Discov. Indexing ... the journal has a 2020 impact factor of 39.397. [6] References
Cellular Oncology is a bimonthly peer-reviewed medical journal published by Springer Science+Business Media. [1] The journal was established in 1989 as Analytical Cellular Pathology, obtaining its current name in 2003. [2] [3] It is an official publication of the International Society for Cellular Oncology and is published
This article about a medical journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.
This article about an oncology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.
The Journal of Clinical Oncology is a peer-reviewed medical journal published 3 times a month by the Lippincott Williams & Wilkins. It covers research on all aspects of clinical oncology. The journal was established in 1983 and the editor-in-chief is Jonathan W. Friedberg (University of Rochester). JCO's Impact Factor is 45.3 as reported by ...
The American Journal of Clinical Oncology is a bimonthly, peer-reviewed, scientific, oncology journal, published by Lippincott Williams & Wilkins. The editor in chief is David E. Wazer (Tufts University). The journal was formerly entitled Cancer Clinical Trials. [1] [2] [3] [4]